Discover free eBooks, guides and med spa templates on our new resources page

ICD-11

ICD-11 Codes
for MA12.2 - Finding of hallucinogen in blood
Teodor Jurukovski January 1, 1970
Fact checked by: Teodor Jurukovski
Use Code

Understanding the Finding of Hallucinogen in Blood

The ICD-11 code MA12.2 specifically denotes the clinical finding of a hallucinogen present in a blood sample. This classification is used to report the detection of these substances, rather than a specific disorder or condition caused by them. It serves as a precise identifier for laboratory results indicating the presence of hallucinogenic drugs.

Identifying Hallucinogens in Blood Samples

The detection of hallucinogens in blood is typically achieved through various laboratory testing methods. These tests analyse a blood specimen to identify the presence and, in some cases, the concentration of specific psychoactive substances. This diagnostic process is crucial for confirming exposure and informing clinical assessments.

Factors Associated with Hallucinogen Detection

The presence of a hallucinogen in a blood sample generally indicates recent or current use of such substances. This finding is often considered within the broader context of a patient's medical history, symptoms, and other diagnostic information. It is a clinical observation that may prompt further investigation into substance use patterns or related health concerns.

ICD-11 Coding for Hallucinogen Findings

For accurate medical documentation and billing, the ICD-11 code MA12.2 is used. This code, officially 'Finding of hallucinogen in blood', ensures that healthcare providers can specifically report this laboratory result. It is a billable code that aids in tracking and managing patient care related to substance detection. The ICD-11 code for finding of hallucinogen in blood is MA12.2.

Associated ICD-11 Classifications

While MA12.2 represents a specific finding, it may be associated with broader categories within the ICD-11 system. For instance, findings of hallucinogens in blood could be relevant when assessing 'Disorders due to use of hallucinogens' (6C49) or other substance-related conditions. Accurate coding ensures comprehensive health records.

Seeking Medical Guidance

If a finding of hallucinogen in blood has been identified, or if there are concerns regarding substance use, consulting with a qualified healthcare professional is recommended. Medical experts can provide appropriate guidance, further diagnostic evaluation, and discuss potential management strategies. This information is for general knowledge and does not constitute clinical advice.

Frequently asked questions

What is the ICD-11 classification meaning of MA12.2?
MA12.2 signifies the finding of a hallucinogen in the blood. This code falls under the category of clinical findings related to drugs, medicaments, and biological substances.
How is the ICD-11 code MA12.2 utilized in clinical documentation?
MA12.2 is used to document the confirmed presence of a hallucinogen in a patient's blood sample, typically identified through laboratory testing.
Does the ICD-11 code MA12.2 specify the particular type of hallucinogen detected in the blood?
MA12.2 indicates the general finding of a hallucinogen. It does not specify the exact substance. Further details regarding the specific hallucinogen would require additional coding or documentation.
×